Patrícia Pinto Saraiva

Patrícia Pinto Saraiva

Auto-generated profile, based on publicly available information

Patrícia Pinto Saraiva

Experimental Research Unit, School of Medicine of Botucatu (FMB), Sao Paulo State University (UNESP), Botucatu, 18618-970, Sao Paulo State, Brazil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
PSP.P. Saraiva
P.P. Saraiva
NFN.B. Figueiredo
N.B. Figueiredo
CPC.R. Padovani
C.R. Padovani
MBM.M. Brentani
M.M. Brentani
CNC.R. Nogueira
C.R. Nogueira
Estrogen involvement in breast cancer has been established; however, the association between breast cancer and thyroid diseases is controversial. Estrogen-like effects of thyroid hormone on breast cancer cell growth in culture have been reported. The objective of the present study was to determine the profile of thyroid hormones in breast cancer patients. Serum aliquots from 26 patients with breast cancer ranging in age from 30 to 85 years and age-matched normal controls (N = 22) were analyzed for free triiodothyronine (T3F), free thyroxine (T4F), thyroid-stimulating hormone (TSH), antiperoxidase antibody (TPO), and estradiol (E2). Estrogen receptor ss (ERss) was determined in tumor tissues by immunohistochemistry. Thyroid disease incidence was higher in patients than in controls (58 vs 18%, P < 0.05). Subclinical hyperthyroidism was the most frequent disorder in patients (31%); hypothyroidism (8%) and positive anti-TPO antibodies (19%) were also found. Subclinical hypothyroidism was the only dysfunction (18%) found in controls. Hyperthyroidism was associated with postmenopausal patients, as shown by significantly higher mean T3 and T4 values and lower TSH levels in this group of breast cancer patients than in controls. The majority of positive ERss tumors were clustered in the postmenopausal patients and all cases presenting subclinical hyperthyroidism in this subgroup concomitantly exhibited Erss-positive tumors. Subclinical hyperthyroidism was present in only one of 6 premenopausal patients. We show here that postmenopausal breast cancer patients have a significantly increased thyroid hormone/E2 ratio (P < 0.05), suggesting a possible tumor growth-promoting effect caused by this misbalance.

18 March 2012 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
MMMariza Akemi Matsumoto
Mariza Akemi Matsumoto
GCGustavo Caviquioli
Gustavo Caviquioli
CBClaudia Cristina Biguetti
Claudia Cristina Biguetti
LHLeandro de Andrade Holgado
Leandro de Andrade Holgado
PSPatrícia Pinto Saraiva
Patrícia Pinto Saraiva
RKRoberto Yoshio Kawakami
Roberto Yoshio Kawakami

6 May 2011 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
VCViviane Carlin
Viviane Carlin
MMMariza Akemi Matsumoto
Mariza Akemi Matsumoto
PSPatricia P. Saraiva
Patricia P. Saraiva
AAAndré Artioli
André Artioli
COCelina T. F. Oshima
Celina T. F. Oshima
DRDaniel Araki Ribeiro
Daniel Araki Ribeiro

6 September 2018 in Genes
Verified
Journal Article
Open access
PDF file
JJJOEL FERREIRA SANTIAGO JUNIOR
JOEL FERREIRA SANTIAGO JUNIOR
Cláudia Cristina BiguettiCláudia Cristina Biguetti
Cláudia Cristina Biguetti
MMMariza Akemi Matsumoto
Mariza Akemi Matsumoto
GKGuilherme Abu Halawa Kudo
Guilherme Abu Halawa Kudo
RSRaquel Barroso Parra da Silva
Raquel Barroso Parra da Silva
Walid FakhouriWalid Fakhouri
Walid Fakhouri
Dental implants provide a predictable treatment option for partial and complete edentulism via the placement of a fixed permanent artificial root to support prosthetic dental crowns. Despite the high survival rates, long-term dental implant failures are still reported, leading to implant removals and additional financial and health burdens. While extrinsic factors that improve the success rate of implants have been well explored, the impact of genetic factors on this matter is poorly understood. A systematic review and meta-analysis study was conducted to determine whether genetic factors contribute to an increased risk of dental implant failures. A comprehensive search for peer-reviewed articles on dental implants and genetic factors was performed using various literature database libraries. The study design was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, and the obtained records were registered in the International Prospective Register of Systematic Reviews (PROSPERO) database. According to the exclusion/inclusion criteria, 13 studies were eligible for this study out of 809 articles. The meta-analysis of the combined association studies of DNA variations and dental implants did not indicate an increased risk for implant failure due to DNA variations in IL-1B, IL-10 and TNF-α. This study emphasizes the need for larger randomized controlled clinical trials to inform clinicians and patients about the role of genetic factors on dental implant survival and the success rate in healthy and compromised patients.

1 February 2016 in The Journal of Contemporary Dental Practice
Verified
Journal Article
Closed access
JSJordan L da Silva
Jordan L da Silva
GKGuaniara D'Arc de O El Kadre
Guaniara D'Arc de O El Kadre
GKGuilherme Ah Kudo
Guilherme Ah Kudo
JJJoel F Santiago Junior
Joel F Santiago Junior
PSPatrícia Pinto Saraiva
Patrícia Pinto Saraiva
Aim: Oral hygiene technique is an important factor in maintaining the health and comfort of hospitalized patients given the frequent presence of oral biofilm and pathogens brought on by mouth breathing. This is an important practice to assist patients in intensive care, in particular those who are intubated and under mechanical ventilation because the realization of oral hygiene reduces the patient's risk of complications and length of hospitalization. The objective of this research was to evaluate the oral health condition of patients hospitalized in an intensive care unit (ICU) and to clarify the importance of protocol standardization involving these patients’ buccal hygiene. Materials and methods: In this study, the sample consisted of 45 patients admitted to an ICU who were evaluated in relation to the oral biofilm score index. Results: The results indicated that there was no significant difference in the biofilm score associated with the genre (p = 0.091), age group (p = 0.549), or teething profile (p = 0.207). However, the biofilm score was greater in partial and fully edentulous patients when compared with dentulous patients. Conclusion: Based on these results, it is recommended that care providers in ICUs complete the relevant oral health care training programs. Clinical significance: When in the ICU, suitable dental conduct following a protocol of prevention of oral biofilm can lead to earlier diagnosis and can prevent the spread of pathogenic microorganisms, particularly those that are systemic in patients with low immunity. How to cite this article: da Silva JL, de O El Kadre GD, Kudo GAH, Santiago JF Jr, Saraiva PP. Oral Health of Patients Hospitalized in the Intensive Care Unit. J Contemp Dent Pract 2016;17(2):125-129.

1 February 2008 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
PSPatrícia P. Saraiva
Patrícia P. Saraiva
STSilvania S. Teixeira
Silvania S. Teixeira
CNCélia Regina Nogueira
Célia Regina Nogueira
CPCarlos Roberto Padovani
Carlos Roberto Padovani
Osteoclastogenesis may be regulated via activation of the RANK/RANKL (receptor activator of nuclear factor-kappa B/ receptor activator of nuclear factor-kappa B ligand) system, which is mediated by osteoblasts. However, the bone loss mechanism induced by T3 (triiodothyronine) is still controversial. In this study, osteoblastic lineage rat cells (ROS 17/2.8) were treated with T3 (10-8 M, 10-9 M, and 10-10 M), and RANKL mRNA (messenger RNA) expression was measured by semiquantitative RT-PCR. Our results show that T3 concentrations used did not significantly enhance RANKL expression compared to controls without hormone treatment. This data suggests that other mechanisms, unrelated to the RANK/RANKL system, might be to activate osteoclast differentiation in these cells.